Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia

Xin Huang, Suxia Geng, Jianyu Weng, Zesheng Lu, Lingji Zeng, Minming Li, Chengxin Deng, Xiuli Wu, Yangqiu Li, Xin DuCancer 2015 · DOI

Abstract

PHTF1 overexpression is responsible for regulating cell proliferation and apoptosis in T-ALL cell lines. PHTF1 may be a tumor-suppressor like gene and a therapeutic target for triggering the PHTF1-FEM1b-Apaf-1 apoptosis pathway.

Introduction

T-cell acute lymphoblastic leukemia (T-ALL) remains a significant clinical challenge due to its aggressive nature and frequent resistance to standard chemotherapeutic regimens. While oncogenic drivers like Notch1 have been well-characterized, the broader regulatory networks governing leukemia cell survival and programmed cell death (apoptosis) are still being mapped.

Recent evidence suggested a potential link between BCL11B—a transcription factor essential for T-cell development—and PHTF1 (Putative Homeodomain Transcriptional Factor 1). This study aims to elucidate the role of PHTF1 in ALL, determining whether it acts as a disease driver or a component of the cellular defense mechanism.

Methods

The researchers utilized a combination of clinical sample analysis and in vitro functional studies:

  1. Clinical Expression Analysis: Real-time quantitative PCR (qRT-PCR) was performed on blood samples from 22 newly diagnosed ALL patients (9 T-ALL, 13 B-ALL) and 10 healthy individuals (HIs). Expression levels of PHTF1, BCL11B, FEM1b, and Apaf-1 were normalized to $\beta2$-microglobulin ($\beta2M$).
  2. Cell Line Manipulation: Human T-ALL cell lines (Jurkat and Molt-4) were subjected to lentiviral transduction to either silence (knock down) or boost (overexpress) PHTF1.
  3. Functional Assays: Cell proliferation was assessed using CCK-8 assays, while apoptosis was quantified via flow cytometry using Annexin-V/PI staining.
  4. Pathway Mapping: Changes in downstream gene expression following PHTF1 manipulation were measured to identify the signaling cascade leading to cell death.

Results

Clinical Expression Patterns

The study revealed significant differences in gene expression between leukemia patients and healthy controls. PHTF1 levels were markedly elevated in both T-ALL ($p = 0.004$) and B-ALL ($p < 0.001$) patients compared to the healthy group. Interestingly, while BCL11B expression was also higher in T-ALL patients, it remained relatively low in B-ALL patients and healthy controls.

Figure 6: Expression levels of PHTF1 (a) and BCL11B (b) in B-ALL, T-ALL, and healthy individuals (HIs).

Functional Impact of PHTF1 Overexpression

Despite its natural overexpression in patients, further artificial boosting of PHTF1 in the lab had a dramatic inhibitory effect on cancer cells. Overexpression of PHTF1 significantly reduced the proliferation of Jurkat ($p = 0.004$) and Molt-4 ($p = 0.007$) cells.

More strikingly, PHTF1 overexpression induced massive apoptosis. In Molt-4 cells, the apoptosis rate surged to 78.67%, compared to 15.50% in the control group ($p = 0.021$).

The PHTF1-FEM1b-Apaf-1 Pathway

The researchers identified the molecular mechanism behind this cell death. Overexpressing PHTF1 in Molt-4 cells led to a 6.3-fold increase in FEM1b (a pro-apoptotic protein) and a 29.4-fold increase in Apaf-1, a critical component of the apoptosome. Notably, PHTF1 levels did not influence BCL11B expression, suggesting that PHTF1 operates through an independent or downstream regulatory pathway.

Discussion

The findings present an "overexpression paradox": PHTF1 is naturally high in leukemia patients, yet its experimental overexpression triggers cell death. This suggests that PHTF1 acts as a "tumor-suppressor-like" gene. Its elevated levels in patients may represent an endogenous, albeit insufficient, attempt by the body to halt malignant progression.

By identifying the PHTF1-FEM1b-Apaf-1 signaling axis, this study highlights a potential therapeutic vulnerability. Artificially activating this pathway could bypass the chemo-resistance often seen in aggressive T-ALL.

Conclusion and Future Directions

While promising, the study has limitations. The clinical cohort was small (n=22), and functional experiments were restricted to T-ALL cell lines despite finding high PHTF1 levels in B-ALL patients. Future research should involve larger patient cohorts, in vivo validation using animal models, and a more detailed molecular analysis of how the PHTF1 protein interacts with the FEM1b promoter.

Summary updated

Abstract

PHTF1 overexpression is responsible for regulating cell proliferation and apoptosis in T-ALL cell lines. PHTF1 may be a tumor-suppressor like gene and a therapeutic target for triggering the PHTF1-FEM1b-Apaf-1 apoptosis pathway.
BibTeX
@inproceedings{huang2015analysis,
  author = {Xin Huang and Suxia Geng and Jianyu Weng and Zesheng Lu and Lingji Zeng and Minming Li and Chengxin Deng and Xiuli Wu and Yangqiu Li and Xin Du},
  title = {{Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia}},
  booktitle = {Cancer},
  year = {2015},
  doi = {10.1186/s12935-015-0242-9},
}
Figure